Soleus Capital Master Fund, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol
RIGL
Shares outstanding
17,666,859 shares
Disclosed Ownership
1,130,679 shares
Ownership
6.4%
Form type
SCHEDULE 13G/A
Filing time
11 Feb 2025, 16:00:35 UTC
Date of event
31 Dec 2024
Next filing
05 Aug 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP LLC 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy